X0306 4 2021-12-03 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001780030 STEPHENSON BRIAN C C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 See Remarks Stock Option (right to buy) 38.62 2021-12-03 4 A 0 211366 0.00 A 2031-12-02 Common Stock 211366 211366 D Restricted Stock Units 2021-12-03 4 A 0 15144 0.00 A Common Stock 15144 15144 D The stock option vests and becomes exercisable as to 25% of the underlying shares on December 3, 2022 and thereafter in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/12th of the remaining underlying shares shall vest on a quarterly basis, so that all of the underlying shares shall be vested on November 16, 2025, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date. Title: Secretary, Treasurer and Chief Financial Officer Yi Ching Yau, Attorney-in-Fact 2021-12-07